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In a  recent communication (1)  we described  a  simple,  rapid,  and practical 
complement fixation method for the diagnosis of poliomyelitis. The procedure, 
which  employs fully infectious fluid  from  tissue  cultures  in  which  the  polio- 
myelitis viruses have been grown, was found to  have  a  very  high  degree  of 
homotypic sPecificity.  To  encourage  the  use  of  the  procedure  in  diagnostic 
laboratories  unfamiliar  with  the handling  of viruses,  it  is highly desirable  to 
remove  the  infection  hazard  by  destroying  the  infectivity  of  the  antigens 
without affecting their complement-fixing activity, and it was thought that this 
might  be  achieved  by  heating.  This  report  deals  with  comparative  studies  1 
on  heated  and  unheated  antigens  and  shows  (a)  that  the  difficulties  with 
heterotypic fixation reported in the literature  are attributable  in large part to 
the use of heated  poliomyelitis complement-fixing antigens  and (b)  that  heat 
treatment uncovers a reactive fraction common to the three virus types. 
Material and Methods 
Poliomyelitis Virus Strains Used.--For the  preparation  of complement-fixing antigens 
the Mahoney (Type 1), Statler  (Type 2), and McMullen  (Type 3) strains  were used. The 
Statler  and McMullen  strains  were isolated in this  laboratory and were used because they 
appeared  to give slightly better antigens than did the MEF-1  (Type 2) and Saukett  (Type 
3) strains. 
For the in vitro neutralization  tests, the Mahoney, the MEF-1,  and Saukett strains were 
used. 
Preparation of Complement-Fixing Antigens.--Of the several lines of HeLa cells in  this 
laboratory,  only the D and the X  lines* are used for the preparation  of poliomyelitis com- 
plement-fixing antigens.  The HeLa cells are routinely  carried in square  200 ml. milk dilu- 
* Aided by a grant from The National  Foundation  for Infantile  Paralysis,  Inc. 
i The report of LeBouvier  (2)  on the modification of polio virus  antigens  by heat and 
ultraviolet  light  appeared  while this  work was in progress, and his findings as they relate 
to the present  work will be discussed when indicated. 
These  cell lines were obtained  from  Microbiological Associates, Bethesda. 
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tion bottles on an outgrowth medium consisting of  i0 per cent human serum and 90 per 
cent lactalbumin hydrolysate-yeast extract) 
Cells to be used for the production of complement-fixing antigen are seeded into a  bot- 
tle  containing an  outgrowth  medium  composed  of  90 per cent  lactaibumin hydrolysate- 
yeast extract medium to which 10 per cent lamb serum is added rather than the human 
serum, as it has been found that cells grown in this medium adhere to the glass better than 
do cells carried exclusively on human serum. 
Antigens were prepared according to the following procedure. 
Milk dilution bottles (200 ml.)  were seeded with 1  X  10  s HeLa cells suspended in  10 
ml. of lactalbumin hydrolysate-yeast extract medium containing I0 per cent lamb serum. 
After incubation at 36°C.  for 2 days,  5 ml. of fresh medium was added to that already in 
the bottles. At 5 days, all of the medium was replaced by I0 ml. of fresh medium. At 7 days, 
5 ml. of fresh medium was added to each bottle, and at 8 days all of the medium was re- 
moved and replaced with I0 ml. of fresh medium. 
Spe.cif~ antig~ were made from cell cultures inoculated with virus on the 9th day. At 
this time the number of cells in each bottle ranged between iS  X  l0  s and 20 X  los. The 
outgrowth medium was removed and the cell sheets were washed twice with Hanks's bal- 
anced salt solution. After the washing, 8 ml. of maintenance medium, consisting of 2.5 per 
cent normal inactivated monkey serum and 97.5 per cent of medium  199  in garle's solu- 
tion was added to each bottle, followed by 0.5 ml. of a  1 X  10  -z dilution of tissue culture 
passage virus. 
The inoculated cultures were incubated for 3 days at 36°C.  The infected fluids were har- 
vested, pooled by virus strain, ampouled in  I0 ml. amounts and stored at  --20°C.  When 
titrations for antigenic activity were performed,  or material was required for testing sera, 
the  contents of  the  requisite number of  ampoules were  thawed,  centrifuged horizontally 
at 2,000 a.p.x¢, for 15 minutes, and the supernatant fluid drawn off for use. 
Control antigens consisted of fluids harvested from uninoculated HeLa cell cultures which 
had been handled as  outlined above for the infected cultures,  including incubation for 3 
days at 36°C.  These fluids served as controls for the detection of possible non-specific com- 
plement-fixing activity and in the test proper were used in 0.2 mi. amounts of a  1:2 dilution. 
Heated antigens consisted of infected or uninfected fluids heated at 56°C for 30 minutes 
in a  water bath. These antigens were never prepared as separate lots of material, but al- 
ways  consisted  of  an aliquot  of a  lot of  unheated antigen.  During heating the container 
was submerged so that the level of the fluid within it was below that of the water level of 
the bath; the inactivation time was counted from the time when the thermometer in  the 
container indicated that the contents had reached 56°C. 
In  Vitro Neutralization  Tests.--Both monkey kidney and HeLa cells were used. 
The colorimetric method described by Salk,  Youngner, and Ward  (3), employing mon- 
key kidney ceils,  was used to determine the neutralizing antibody level of certain  sera, and 
the colorimetric method of Lipton and Steigman (4)  based on the use of HeLa cells, was 
used with other sera.  The technic employed is indicated in the tables. 
Titration  of  Antigens.--The  potency  of  each  antigen  preparation  was  determined 
in  "checkerboard"  or  "block"  titrations with hyperimmune  monkey  serum;  in  this pro- 
cedure,  falling dilutions of  the antigen are  tested  against falling dilutions of the immune 
serum.  The titration endpoint which represents 1  unit of antigen is defined as  that dilu- 
tion of antigen which gives three plus or four plus fixation with the highest dilution of im- 
mune serum. 
S The  lactalbumin  hydrolysate--yeast  extract  medium  has  the  following  composition: 
Lactalbumin hydrolysate, 0.5 per cent; glucose, 0.45 per cent; yeast extract, 0.1 per cent; 
and sodium bicarbonate, 0.11  per cent. 
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In the complement fixation test proper, 2 units of antigen contained in 0.2 ml. were used. 
Complemen$.--Lyophilized  complement  was  used  throughout  this  work;  it  was  recon- 
stituted in the fluid supplied by the manufacturer. Complement was titrated in the pres- 
ence of each specific antigen and two exazt units in a volume of 0,2 ml. were used in the tests. 
The incubation period for the  titration was  1 hour at  37°C. 
Hemolysin.--Two units of hemolysin in 0.25 ml. as determined by titration at 37°C. for 
30 minutes with 1:30 complement (0.2  ml.)  and a  2.0 per cent sheep cell suspension (0.25 
ml.) were used. 
Sensitized Cells.--Sensifized  cells were prepared by mixing equal volumes of a  2 per cent 
suspension of sheep erythrocytes and a  dilution of hemolysin containing 2 hemolytic units 
in a  volume of 0.25 ml. The mixture was allowed to stand at room temperature for 10 min- 
utes before use. 
Procedure for  the  Complement Fixation  Test.--Sera  were  diluted  1:4  in  Kolmer  saline 
solution  and  inactivated  at  60°C.  for  30  minutes.  (Occasionally,  because the amount  of 
serum available was inadequate to permit a  dilution series beginning at  1:4, the specimen 
was diluted 1:8 before inactivation.) Mter inactivation, serial 2-fold dilutions of each serum 
were prepared in Kolmer saline solution. Each dilution was prepared in adequate amounts 
to permit dispensing into a  series of tubes so that tests against the various antigens could 
be run concurrently. In addition, the first two dilutions of each serum were tested for anti- 
complementary  activity in  the  absence  of  antigen,  and  for  possible  non-specific comple- 
ment-fixing activity with control antigens. Antigen diluted to contain 2  units in a  volume 
of 0.2 mi. was added, followed by 0.2 ml. of complement dilution containing 2 exact units. 
Fixation was  allowed  to  proceed  at  4°C.  overnight  (approximately  18 hours).  The  tubes 
were then warmed in a  37°C. water bath for 10 minutes, 0,5 nil. of sensitized cells was ad- 
ded to each tube, and secondary incubation was conducted for 15 to 30 minutes, depending 
upon  the time required  for  the  complement control tubes to  show  clearing.  The  comple- 
ment  controls consisted  of  a  series of  four  tubes  containing antigen,  sensitized red  cells, 
and 2 units, 1~  units, I  unit, and ~  unit of complement, respectively. The tubes contain- 
ing  1,  1~,  and 2  units should show clearing after  15 to 30 minutes of incubation, and as 
soon as this occurred the tests were read. The titer of a  serum was the highest dilution (ini- 
tial, not final)  showing three plus  or four plus fixation with the specific antigen. 
Monkey  Hyperimmune  Serum.--Specific monovalent immune sera  for  use  in  the  com- 
plement  fixation and  in  vitro neutralization tests were  prepared  in rhesus monkeys.  The 
Mahoney,  MEF-1,  and  Sankett  strains were  used.  The  animals were  inoculated into the 
calf muscles at biweekly intervals for a  total of three or four inoculations with 2  ml.  of a 
mixture  of  adjuvant  and  infected fluid  from  monkey kidney  tissue cultures  of  the  virus. 
The adjuvant consisted of one part of arlacel A  in nine parts of standard mineral oil  C.T. 
70.  4 Equal parts of the adjuvant mixture and culture fluid were emulsified by vigorous shak- 
ing in a  vaccine vial containing glass beads. 
The hyperimmune serum prepared in this manner was type-specific in the complement 
fixation and neutralization tests. The complement-fixing antibody titers of the sera against 
the homologous antigens were  usually  1:1024 and  the neutralizing titers in metabolic in- 
hibition tests were  1:16,384 or higher. 
RESULTS 
Effect of Heat on Complement-Fixing Potency and Sensitivity  of the Antigens.-- 
Svedmyr et al.  (5, 6) reported that their tissue culture antigens had to be concen- 
trated to give usable preparations, and that concentration resulted in the appearance 
4 Arlacel was  generously provided by the Atlas Powder  Company,  Wilmington.  Stand- 
ard mineral oil C.T.70 is a  product of the Standard Oil Company of California, Richmond. 102  POLIOMYELITIS  C-F  ANTIGENS 
of anticomplementary activity. Black and Mdnick (7)  also encountered  difficulties 
with the anticomplementary proclivities  of some of  their tissue  culture antigens. 
Both groups found that this undesirable property could be abolished by heat treat- 
ment (54°C. to 60°C. for 30 minutes  (5) or 56°C. for 30 minutes (7)) and that the 
ability of the antigens to fix complement in the presence of homotypic monkey im- 
mune serum was not destroyed (5, 6, 8). Black  (9) states that heating the virus at 
56°C. for 30 minutes destroys the infectivity without significantly reducing or broad- 
ening the antigenidty. 
As quantitative data were not available on the possible adverse effects of 
heat on the sensitivity and potency of tissue culture fluids used as antigens, a 
comparison of heated and unheated antigens was made with respect to  these 
properties.  Four different lots of Type 1 antigen, six of Type 2, and three of 
Type 3 were assayed. An aliquot of each antigen was heated, and the heated 
and unheated preparations were examined concurrently with homotypic mon- 
key immune serum. The results are given in Tables I,  II and III, in which 
the titration endpoints (antigenic units) are indicated. 
That heating quantitatively affects the potency of the antigens is illustrated 
in Table I, which shows that all four lots of the Type 1 antigen suffered a reduc- 
tion in fixing capacity after heat treatment. The antigenic titer of antigen 6199 
was lowered from 1:8 to  1:6; of antigen 6193,  from 1:6  to  1:4; of antigen 
5033,  from 1:6 to 1:3, and of antigen 3388,  from  1:4 to 1:3. While, at first 
glance, the reduction  in  titer may appear  quantitatively insignificant, it  is 
relatively large. Thus, heating preparations 6199  and 5388  resulted in a  25 
per cent loss in fixing capacity and heating of antigens 6193 and 3033 resulted 
in a 30 per cent and 50 per cent loss in potency respectively. On the applied 
side,  losses  in fixing capacity such as a  loss  encountered with antigen 5033 
would necessitate twice the amount of heated antigen to do the same number 
of examinations possible with unheated material. 
In addition to the loss of antigenic potency with heating, there was a  con- 
comitant loss in sensitivity. For example, antigens 6199 and 6195, which when 
used undiluted gave a  serum endpoint titer of 1:2048,  gave a  titer of only 
1:512 after heating. This is also illustrated by the fact that, if the antigenic 
unit is taken as the endpoint of the titration, 1 unit of unheated antigen con- 
sistently gave fixation with one 2-fold higher dilution of immune serum than 
did the headed antigen. These findings agree with those just recently reported 
by LeBouvier (2). 
The results of comparative titrations of heated and unheated Type 2 comple- 
ment-fixing antigens of six different lots are given in Table II. The potency of 
five of the six antigens was reduced by heating. The effects of heating were most 
marked in antigen 6350, whose titer (antigenic unit) dropped from 1: 8 to 1: 3. 
The titer of antigen 6349 decreased from 1:8 to 1:4 and that of antigens 6114, 
6334, and 6335 decreased from 1:4 to 1:3. The antigenic titer of antigen 6340 TABLE  I 
Comparison of Potency and Sensitivity  of Heated and  Unheated Typ~ 1 PolioraydRis Virus 
Complement-Fixing Antigens Tested with Homologous Monkey Immune Serum 
Results obtiined  with; 
Dilution  of Antigen  Unheated  antigen  Heated antigen 
Dilutions  of immune  serum  Dilutions  of immune  serum 
Antigen 6199 
Undiluted  4+ 
1:2  14+ 
1:3  4+ 
1:4  4+ 
1:6  4+ 
1:8  4+ 
1:10  4-}- 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  ~+~,/* 
4+  2+ 
Titer =  1:8 
3+  4+ 
2+  4+ 
1+  4+ 
0  4+ 
0  4+ 
o 
0 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+ 
0 
Titer =  1:6 
Antigen 6195 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
1:10 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+  4+  4+ 
4+  :4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+ 
4+  3+  0 
2+  0  0 
~ter=  1:6 
3+  4+ 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  1+ 
0  0 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+/ 
4+  1+ 
0  0 
0  0 
Titer =  1:4 
Antigen 5033 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4+  4+  4+  3+ 
4+  4+  4+  1+ 
4+  4+  4+  0 
4+  4+  4+  0 
4+  4+  4+/  0 
4+  2+  6--  o 
~ter=  1:6 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
4+  4+ 
4+  4+ 
4+  4+/ 
4+  ~-- 
4+  0 
2+  0 
Titer -- 1:3 
2+ 
2+ 
0 
0 
0 
0 
Antigen 5388 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4+ 
4+ 
4+ 
4+ 
4+ 
0 
4+  4+  3+ 
4+  4+  4+ 
4+  4+  3+ 
4+  4+  3+/ 
4+  1+  0-- 
0  0  0 
TRer= 1:4 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  3+/ 
4+  4+  ~-" 
4+  1+  0 
0  0  0 
~ter ffi 1:3 
1+ 
0 
0 
0 
0 
0 
* __/  =  Antigenic endpoint of titration. 
Antigens prepared from Mahoney strain, Type 1 virus. 
Immune sera prepared against Mahoney strain, Type 1 virus. 
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TABLE II 
Comparison of Potency and Sensitivity  of Heated and  Unheated Type 2 Poliomyelitis  Virus 
Complement-Fixing Antigens  Tested with Homologous Monkey Immune Serum 
Results obtained with: 
Dilution of antigen  Unheated antigen  I: 2048  Heated antigen 
Dilutions of immune serum  Dilutions of immune serum 
1:128[ 1:256[  1:$12  ]  1:1024  [  1:128  1:256  ]  1:512  11:102411:2048 
Antigen 6350 
Undiluted 
1:2 
1:3 
1:4 
1:4 
1:6 
1:8 
1:10 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
3+ 
4+  14+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  3+/* 
0  0 
'liter =  1:8 
2+  4+ 
4+ 
4+ 
4+ 
4+ 
0 
0 
0 
4+  4+ 
4+  4+ 
4+  4+/ 
4+  0 
4+  0 
0  0 
0  0 
0  0 
Titer =  1:3 
2+  + 
Antigen 6349 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
1:10 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  [4+ 
4+[2+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+/ 
o  6- 
2+  4+ 
2+  4+ 
1+  4+ 
0  4+ 
0  4+ 
0  4+ 
0  0 
Titer =  1:8 
Antigen 6340 
4+  0 
4+  -4- 
3+ 
3+/  o 
2+  0 
1+  0 
0  0 
Titer =  1:4 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4+ 
4+ 
4+ 
4+ 
4+ 
0 
4+  4+  0 
4+  4+  0 
4+  4+  0 
4+  4+/  o 
0  6--  0 
0  0  0 
Titer =  1:4 
4+ 
4+ 
4+ 
4+ 
4+ 
0 
4+  0 
4+  0 
4+  0 
4+/  o 
o 
0  0 
Titer =  1:4 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
Antigen 6335 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4+ 
4+ 
4+ 
4+ 
0 
0 
4+  4+  0 
4+  4+  0 
4+  4+  0 
4+  3+/  0 
0  0---  0 
0  0  0 
Titer =  1:4 
4+ 
4+ 
4+ 
4+ 
4+ 
0 
4+  4+ 
4+  4+ 
4+  3+/ 
4+  ~-- 
3+  0 
0  0 
Titer =  1:3 
0  0 
0  0 
0  0 
0  0 
0  0 
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TABLE II--Concluded 
Results obtained with: 
Dilution of antigen  Unheated antigen  Heated antigen 
Dilutions of immune serum  Dilutions of immune serum 
Antigen 6114 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+  4+  1+ 
4+  4+  0 
4+  4+  0 
4+  4+__~/  0 
3+  2+  0 
0  0  0 
Titer ~  1:4 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  0 
0  0 
4-t-  0 
4+  0 
3+/  0 
~-~  o 
0  0 
0  0 
Titer -  1:3 
Antigen 6334 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4+ 
4+ 
4+ 
4+ 
4+ 
-4- 
4+  4+  2+ 
4+  4+  ± 
4+  4+  0 
4+  4+/  0 
3+  ~-  0 
0  0  0 
Titer -- 1:4 
0  4+ 
0  4+ 
0  4+ 
0  3+ 
0  0 
0  0 
4+  0 
4+  0 
4+/  o 
~--  o 
0  0 
0  0 
Titer  -- 1:3 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
* _/--  Antigenic endpoint of titration. 
Antigen prepared from Statler strain, Type 2 virus. 
Immune sera prepared against MEF-1 strain, Type 2 virus. 
was  1:4  both  before and after heating.  With the exception of antigen 6335, 
there was also a  lowering of the serum endpoint titer. In four of the antigens, 
v/z., 6114,  6334,  6340,  and 6350,  the serum titer was decreased by one 2-fold 
dilution but in antigen 6394 it was decreased by two 2-fold dilutions; i.e., from 
1:1024 to 1: 256. 
Three  different lots of Type 3  antigen  were  tested.  Interestingly enough, 
heating did not affect the antigenic titer of any of the three lots, although as 
inspection of Table III will show, sensitivity was affected just as in the case of 
the Type 1 and Type 2 antigens. 
Some of our findings on the effect of heat agree with those recently reported by 
LeBouvier (2) while others apparently do not. LeBouvier reported that the degree of 
fixation obtained with heated antigen (60°C. for 20 minutes) and homotypic monkey 
immune sera was regularly less than that with the unheated antigen. If the Type 3 
strain used is representative of Type 3 strains in general, the question arises as to 
why the Type 3 antigen was essentially  unaffected by heating, whereas such treatment 
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TABLE III 
Comparison of Potency and Sensitivity  of Heated and  Unheated Type 3 Poliomyelitis  Virus 
Complement-Fi~ng Antigens Tested with Homologous Monkey Immune Serum 
Dilution of antigen 
Results obtained with 
Unheated antigen  Heated antigen 
Dilutions of immune serum  Dilutions of immune serum 
Antigen 6200 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
1:10 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  3-4-/* 
3+  2+  o 
Titer =  1:8 
2+  4+ 
1+  4+ 
4-  4+ 
0  4+[ 
0  4+ 
o  4+' 
0  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+/ 
2+  0 
Titer =  1:8 
3+ 
4- 
0 
0 
0 
0 
0 
Antigen 5708 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
4-[- 
4+ 
4+ 
4+ 
4+ 
4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+ 
0  0 
~ter=  1:6 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  0 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+ 
0 
Titer =  1:6 
Antigen 6324 
Undiluted 
1:2 
1:3 
1:4 
1:6 
1:8 
1:10 
4+ 
4+ 
4+ 
4+ 
4+ 
4- 
0 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+/ 
3+  2+  6-- 
0  0  0 
0  0  0 
Titer =  1:4 
4-  4+ 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  4+ 
0  0 
4+  4+ 
4+  4+ 
4+  4+ 
4+  4+/ 
4+  Y~ 
0  0 
0  0 
Titer =  1:4 
2+ 
l+ 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
* __/  =  Antigenic endpoint of titration. 
Antigens prepared from McMullen strain,  Type 3 virus. 
Immune sera prepared against  Saukett  srain, Type 3 virus. 
resistance of the Type 3 antigen does not accord with LeBouvier's observations, as he 
found that in conversion of poliomyelitis antigens from the Y  (unheated)  to the H 
(heated) form, the Type 3 virus was the most susceptible of the three types. He noted 
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poliovirus antigens over different ranges of temperature, the Type 3 virus ceasing to 
react with its  'standard' monkey antiserum  after 20 minutes at  70°C.,  the Type 2 
at 80°C., and the Type 1 at 90°C. '' 
Reactivity of Heated Antigens with Heterotypic Monkey Immune Sera.--The 
effect of heat on the homotypic specificity of the antigen was next investigated. 
Heating of poliomyelitis complement-fixing antigens has been a routine or frequent 
practice to abolish either infectivity or anticomplementary action (5-11).  Svedmyr 
et al. (5, 6) reported that their antigens (heated) gave no cross-reactions with hetero- 
typic monkey immune sera,  and  Black and  Melnick  (12)  stated  that  their  heated 
TABLE IV 
Reactivity with Monkey Immune Sera of Heated and Unheated Poliomyditis Virus Complement- 
Fixing Antigens 
Monkey  No.  Immune serum 
Type 1 (Mahoney) 
Type 1 (Mahoney) 
Type 2 (MEF-1) 
Type 2 (MEF-1) 
Type 3 (Saukett) 
Type 3 (Saukett) 
Complement-fixing titer of immune serum with 
Unheated antigen of  Heated antigen of 
Type~ 
1024 
1024 
<8 
<8 
<8 
<8 
Type~ 
<8 
<8 
2O48 
2O48 
<8 
<8 
Type3 
<8 
<8 
<8 
<8 
512 
256 
Type  I  Type  2 
512  <8 
256  <8 
<8  1024 
8  512 
<8  <8 
<8  <8 
Type 3 
<8 
<8 
<8 
8 
512 
128 
Antigens prepared from the Mahoney, Statler,  and  McMullen strains of Types 1, 2, and 
3 viruses, respectively. 
preparations  were  not cross-reactive with  monkey immune  serum.  However,  since 
the complement-fixing method used by the workers in the references just  cited is a 
plate or micro method (13), information was desired on whether heated antigens would 
show heterotypic reactivity in the macro method (tube test) that we described (1). 
Table IV summarizes briefly the results obtained when heated antigens were 
tested  with  heterotypic  monkey immune  sera.  Each  serum  was  examined  in 
the "line test" in which serial 2-fold dilutions of serum were tested with 2 units 
of antigen,  as determined by checkerboard titrations.  It will be observed that 
the unheated  antigens gave sharp,  homotypic fixation--no cross-reactions be- 
tween  virus  types  occurred  in  these  experiments.  After  heat  treatment,  the 
Type 2 antigen still showed completely homotypic activity. The heated Type 
1 and Type 3 antigens, however, appeared to give a small degree of fixation with 
the Type 2 antiserum from monkey 4. The significance, if any, of this one dis- 
crepant result is not assessable at  the moment, especially since fixation was at 108  POLIOMYELITIS  C-F  ANTIGENS 
threshold  levels.  However,  the  virtually  complete  absence  of  heterotypic 
activity on the part of the heated antigens in the tube complement fixation 
test is in substantial agreement with the findings of others  (6,  12)  using the 
plate method. Why heated antigens should relatively uniformly give sharply 
homotypic fixation with monkey immune sera but react heterotypically with 
human sera  (see next section)  is unclear. 
Recent observations indicate  that some modification  of the  antigenic  structure 
occurs on exposure  of the virus to formalin (7), heat (2), and ultraviolet irradiation 
(2).  We  (unpublished  data)  and others  (7)  have observed that immune sera from 
monkeys inoculated  with monovalent, formalinized virus preparations react hetero- 
typically in the complement fixation test. Black and Melnick (12) recently reported 
that tissue culture antigens, with sharply homotypic reactivity in their native state, 
became cross-reactive after treatment with formalin and suggested as one possibility 
that the broadened reactivity might be caused by exposure of a previously masked 
group antigen. LeBouvier (2) found that monkeys inoculated with heated virus de- 
veloped antibodies which  reacted to a higher titer with heated than with unheated 
antigens, while monkeys inoculated with unheated, fully active virus developed anti- 
bodies which reacted to a higher titer with unheated than with heated antigens. The 
reactions were primarily homotypic with occasional  small degrees  of cross-reaction, 
serum titers of 1 : 1 or up to 1:8 being shown by some of the test antisera with hetero- 
typic complement-fixing  antigens; cross-reactions  were greater with heated than with 
unheated heterotypic antigens. 
Effect of Heat on Homotypic Specificity of Antigens  Used  for Antibody Assay 
of Human Sera.--In a previous communication (1), we presented data illustrat- 
ing the high degree of type-specific fixation encountered by us with human sera. 
It was considered possible that the relative freedom from cross-reactions might 
be due to the use of untreated, fully infectious antigens since others, who have 
reported  a  high  degree of heterotypic reactivity,  have used  heated  antigens 
(5-11).  Svedmyr (10),  for example, recently reported that in a  series of 137 
cases of poliomyelitis, the complement fixation test was positive in 90 per cent, 
but only 10 per cent showed type-specific reactions. Black (9), however, states 
that heating does not significantly broaden the antigenicity. 
As no specific information was available in the literature as to the basis for 
these heterotypic reactions, a quantitative comparison of heated and unheated 
antigens was undertaken. 
Each batch of antigen, heated or unheated, was titrated to determine the antigenic uni- 
tage, and line tests were done using 2 units of antigen and falling 2-fold dilutions of serum. 
Fifty sera were selected from a group on which neutralization tests had already been done, 
so as to include in the experiments sera with no demonstrable neutralizing antibody to one 
or another virus type, to two types, etc. 
The results with the 50 sera are presented in Table V, in which the sera are 
arranged in order of increasing complement-fixing antibody to the Type 1 virus 
as determined by the use of unheated antigen. TABLE  V 
Effect of Heat on Homotypic Specificity of Poliomyelitis Complement-Fixing Antigens  Used 
for Antibody Determinations of Human Sera 
Serum  Poliomyelitis C-F titer of serum with 
Unheated antigen of  Series  Accession 
No.  No.  Type 1  Type  2  Type  3  Type  1 
1  54/712  <4  <4  <4 
2  55/55  <4  <4  <4 
3  1312  <4  4  <4 
4  6945  <4  8  <4 
5  7920  <4  8  8 
6  1027  <4  16  4 
7  7976  <4  32  4 
8  6581  <4  32  8 
9  5895  <4  64  16 
10  5725  <4  64  64 
11  7026  <4  64  64 
12  6522  <4  4  <4 
13  1543  <4  16  <4 
14  2882  4  <4  <4 
15  6521  4  4  4 
16  167  8  <4  <4 
17  6406  8  <4  4 
18  1007  8  <4  8 
19  592  8  <4  8 
20  7629  8  <4  64 
21  7242  8  <4  8 
22  1336  8  <4  <4 
23  497  8  4  8 
24  4714  8  8  8 
25  7575  8  8  16 
26  1151  8  16  8 
27  7314  8  16  16 
28  3919  8  16  16 
29  165  8  32  16 
30  4706  16  4  8 
31  7288  16  <4  8 
32  8809  16  4  16 
33  7943  16  <4  16 
34  8639  16  <4  32 
35  6240  16  4  32 
36  8345  16  <4  32 
37  54/69  16  <4  8 
38  8419  16  <4  16 
39  6359  16  16  32 
40  8055  32  <4  8 
41  54/74  32  <4  8 
42  5131  32  <4  8 
43  7826  32  <4  16 
44  2904  32  <4  16 
45  1155  32  <4  16 
46  7977  32  <4  16 
47  7751  32  <4  16 
48  7476  32  <4  16 
49  7921  32  <4  8 
50  1348  64  <4  16 
Heated antigen of 
Poliomyelitis-neutralizing 
antibody titer 
Type 2  Type 3 
<4 
<4 
4 
16 
8 
4 
32 
64 
16 
64 
64 
4 
<4 
<4 
4 
<4 
<4 
4 
4 
32 
<4 
<4 
4 
8 
8 
16 
8 
16 
32 
<4 
4 
16 
4 
8 
32 
32 
8 
8 
32 
<4 
4 
4 
<4 
<4 
4 
16 
16 
16 
8 
8 
Type 1  Type  2  Type  3 
<4  <4  16 
<4  <4  128 
<4  <4  256 
<4  <4  128 
<4  <4  128 
64  <4  128 
<4  (4  512 
<4  <4  1024 
64  16  512 
<4  <4  2048 
<4  <4  1024 
<4  256  4 
<4  1024  128 
128  <4  <4 
256  8  <4 
256  <4  <4 
256  <4  <4 
128  <4  <4 
512  <4  <4 
1024  <4  <4 
64  512  <4 
256  512  8 
128  <4  8 
128  <4  64 
256  16  512 
256  <4  16 
256  16  1024 
256  <4  64 
1024  16  512 
1024  <4  8 
1024  <4  <4 
512  8  128 
512  <4  <4 
1024  8  8 
512  <4  <4 
2048  16  8 
1024  1024  <4 
256  256  <4 
512  64  1024 
512  <4  <4 
1024  <4  <4 
2048  <4  <4 
512  <4  <4 
4096  <4  *£4 
2048  <4  <4 
512  <4  <4 
512  <4  <4 
512  <4  <4 
1024  1024  <4 
1024  <4  64 
Neutralizing antibody titers determined by the colorimetric method of Salk et al. (3) using 
a monkey kidney tissue culture system. 
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Comparison of the complement fixation test results using unheated antigen 
with the results of the neutralization tests in Table V shows that an occasional 
serum contained no demonstrable complement-fixing antibody to a virus type 
although neutralizing antibody to that type was present (for example, serum 
specimens 6, 9, 15, 22). On the other hand, with a single exception (serum 15), 
complement-fixing antibody was not demonstrable in the absence of the cor- 
responding homologous neutralizing antibody. In marked contrast, comparison 
of the results of complement fixation tests using heated antigen with the results 
of the neutralization tests shows a very significant level of heterotypic fixation. 
Thus, 16 of the 50 sera gave fixation of 1:4 or higher with an antigen against 
TABLE VI 
Reactivity of Heated Poliomyelitis Virus Antigens. Fixation of Complement with Human Sera 
Containing No Demonstrable Neutralizing Antibody  Corresponding to the Immunologic 
Type of Antigen Used 
No. of 
seta 
tested 
50 
Sera with 
no demon- 
strable 
neutral- 
izing 
antibody* 
to 
Type 1 
Type 2 
Type 3 
Results of complement  fixation tests with heated antigens 
No. of sera giving fixation:~ 
with a single heterotypic 
antigen, viz. 
Sera with no 
de~nonstrsble 
neutralizing 
antibody* to 
No, of sera giving fixatlon~ with 
two heterotypic antigens, ~iz. 
Type 1  Type 2  Type 3  Types 1  Types 2  and 3  and 3  aT~nd  2  ! 
Typesland3  1 (2%) 
12 (24%)  Types 2 and 3  12 (24%) 
4 (8%)  Types 1 and 2  4 (8%) 
* Neutralizing antibody titers of less than 1:4. (Colorimetric method of Salk et at.  (3) 
using monkey kidney tissue culture system). 
:~ Complement-fixing  titers of 1:4 or more. 
whose immunologic type there was no detectable neutralizing antibody in the 
serum and an additional 17 sera gave fixation (1:4 or higher) with two antigens 
against  whose  immunologic  types  there  was  no  demonstrable  neutralizing 
antibody. 
The extent of the cross-reactions is summarized in Table VI by immunologic 
type of virus. It will be seen that of the sera which gave cross-reactions against 
a  single virus type, no instances were encountered in which a  serum with no 
demonstrable Type 1 neutralizing antibody gave fixation with a heated Type 1 
antigen. However, 12 sera  (24 per cent)  containing no demonstrable Type 2 
antibody gave fixation with a Type 2 antigen, and four sera (8 per cent) con- 
taining no Type 3 antibody gave fixation with a Type 3 antigen. With respect 
to fixation against multiple antigens, one serum containing neither Type 1 nor 
Type 3 antibody gave fixation with Type 1 and Type 3 antigens. Twelve sera 
(24 per cent) containing no Type 2 or Type 3 antibody gave fixation with Type N. J. SC~IDT  AND  E. H. LENNETTE  111 
2 and Type 3 antigens, and four sera (8 per cent) containing no Type 1 or Type 
2 antibody gave fixation with Type 1 and 2 antigens. 
Summation of the left- and right-hand portions of Table VI, i.e. the number of 
sera which reacted heterotypically with one type and the number of sera which 
reacted  heterotypically with  two  types,  shows  that  in  the  series  of  50  sera 
tested, 5,  or  10 per cent,  gave heterotypic fixation with Type  1 virus; 28,  or 
56 per cent, gave heterotypic fixation with Type 2 virus; and 17, or 34 per cent, 
fixed heterotypicaly with the Type 3 virus. 
These 50 sera were tested on three different occasions with three different lots of 
Type 1 and Type 3 antigens and four different lots of Type 2 antigen, so that the 
differences between the results obtained with heated and unheated materials are not 
ascribable to some peculiarity in any one test or antigen. The loss of homotypic speci- 
ficity of the heated antigens was apparently due to an alteration of the virus or its 
end-products rather than to a  change in some component of the HeLa cell cultures, 
as the sera did not react with heated  control antigens prepared from non-infected 
HeLa cell cultures. 
Before attempting  to  interpret  the significance of cross-reactions,  ancillary 
data seemed desirable on the time of appearance of these heterotypic comple- 
ment-fixing substances, whether rises in their level occurred, the titers encoun- 
tered,  and whether  they tended  to  persist.  To  obtain  information  on  these 
points,  paired or multiple  serum  specimens from  20  patients  with a  clinical 
diagnosis of poliomyelitis were examined. 
Of these 20 patients, one, an infant, apparently did not have poliomyelitis despite the 
clinical diagnosis, one patient had a Type 3 virus infection, and the remaining  18 had Type 
1 virus infections.  The results are presented in Table VII, which  gives  the complement- 
fixing antibody levels as determined with both heated and unheated antigen and the neu- 
traliziug antibody titers as determined by the colorimetric  method using  HeLa cells  (4). 
The serum of patient 1, from  whom no poliomyelitis virus was isolated, contained no de- 
monstrable neutralizing antibody for the poliomyelitis viruses,  nor was complement-fixing 
antibody detectable using either unheated or heated antigen. 
Patient 2 had neutralizing antibodies only to the Type 3 virus, and this was reflected 
by the complement  fixation test with the unheated antigen which showed no demonstrable 
complement-fixing antibody to Types 1 or 2 but a rise in titer to Type 3; the heated anti- 
gen,  however,  indicated a  rise in Type 2  complement-fixing  antibodies and  a  stationary 
titer to Type 3.  (The titers obtained with the Type 1 heated antigen are within the experi- 
mental error  (2-fold differences)  of the method and are not  regarded  as significant.) 
Of the 18 individuals with Type 1 infections,  all showed 4-fold or greater rises in com- 
plement-fixing antibody titer with the unheated antigen except patients 17 and 20 in whom 
only 2-fold rises, not significant  diagnostically, were encountered.  It will also be seen that 
with  the unheated  antigen no heterotypic responses  were  encountered;  in  patient 5,  the 
rise from less than 1:4 to 1:4 with the Type 3 antigen is not significant,  nor is the 2-fold 
rise against the Type 3  virus in patient 7 significant.  The appreciable amount of Type 3 
complement-fixing  antibody in patient 7 as revealed by the unheated antigen is compat- 
ible with the high neutralizing antibody present to this type. This situation is different from 
that  encountered  in this group of patients when  heated antigen was used.  Patients 4,  6, 112  POLIOMYELITIS  C-i  ~ ANTIGENS 
TABLE VII 
Loss of Homolypic Specificity of Poliomyelitis  Virus Comflement-fixing  Anligens  after 
He~t Treatment 
Patient 
1.  Sh.St. 
2.  Li.Ro. 
3.  Ro.Mo. 
4.  Ca.Et. 
5.  Gr.Br. 
6.  Ka.McH. 
7.  Be.Cu. 
8.  Sa.Co. 
9.  Ca.Cu. 
10.  Ge.Wo. 
11.  Su.Gr. 
12.  Ro.Sk. 
13.  Ma.Bo. 
14.  Wi.Bu. 
15.  An.Go. 
Poliomyelitis complement 
~ation tlters  Poliomyelitis 
neutralizing 
Clinical  Virus  antibody 
Days  t~v~pe  of  I  isolated  Unheated  titer*  Age  Sex  after  Heated antigen  ponomye-  from  antigen 
onset  IRIS  stool  ., 
TYpe Type  tYpe Type Type Type Type ~pe  rype 
1  2  3  1  2  3  1  2  3 
10  mos.  F  7  Paralytic None  <4  <4  <4  <4  <4  <4  <4  <4  <4 
36  <4  <4  <4  <4  <4  <4  <4  <4  <4 
15 yrs.  F  7  Paralytic  Type 3  <4  <4 
30 
31 yrs.  M  7  Paralytic  Type 1 
29 
8 yrs.  F  2  Paralytic  Type 1 
17 
31 yrs.  F  6  Non-par-  Type I 
25  alytlc 
8 yrs.  F  7  Contact  TYpe 1 
21 
49 
12  yrs.  F  5  Paralytic Type l 
21 
35 
8  <4  4  16  <4  <4  128 
<4  <4  32  4  32  32  <4  <4  512 
<4  <4  <4  64  16  32  32  32  <8 
16  <4  <4  16  8  8  256  16  <4 
<4  <4  <4  <4  8  8  <4  <4  <4 
16  <4  <4  16  64  64  256  <32  <32 
<4  <4  <4  16  32  64  32  8  512 
16  <4  4  16  32  64  128  <4  512 
<4  <4  <4  <4  4  4  <4  <4  <4 
8  <4  <4  16  32  32  64  <4  <4 
15  <4  <4  8  16  16  128  <4  <4 
<4  <4  32  <4  8  16  <16  <16  128 
16  <4  64  16  16  32  128  64  128 
32  <4  64  16  16  32  512  128  128 
2 yrs.  M  3  Paralytic  TYpe 1  <4  <4  <4  <4  <4  16  16  <4  <4 
27  32  <4  <4  32  <4  8  128  <4  <4 
4 yrs.  F  8  Paralytic  Type 1  <4  <4  <4  <4  <4  <4  <16  32  <16 
35  64  <4  <4  32  <4  8  512  16  <4 
2 yrs.  M 
1 yr.  F 
6 yrs.  M 
3  Paralytic  Not  <4  <4  <4  16  32  8  128  64  <4 
17  done  64  <4  <4  32  16  16  256  64  <4 
I0  Paralytic  !TYpe1  <4  <4  <4  <4  <4  <4  <4  <4  <4 
i 
32  64  <4  <4  32  4  4  128  <4  <4 
I 
3  Paralytic  ]Type !  4  <4  <4  64  32  32  32  <4  <4 
17  32  <4  <4  32  32  16  64  <4  <4 
31  32  <4  <4  32  32  32  128  <4  <4 
7 yrs.  F  8  Paralytic  Type 1  4  <4  <4  16  16  16  64  16  8 
22  32  <4  <4  32  16  16  128  <4  <4 
36  32  <4  <4  16  16  16  128  <8  <4 
9 yrs.  M  7  Paralytic  Type 1  4  <4  <4  64  32  32  8  <4  <4 
27  64  <4  <4  64  32  16  128  <4  <4 
$ yrs.  F  6  Paralytic  Type 1  <8  <8  <8  32  16  16  64  32  <4 
17  8  <4  <4  16  8  8  256  64  8 
40  32  <4  <4  16  4  8  256  64  4 N.  J.  SCHMIDT  AND  E.  H.  LENNETTE 
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Patient 
16. Je.Wi. 
17.  Et.Sc. 
18.  Do.EL 
19.  Sh.v.Vl. 
20.  Mi.Ba. 
Age 
29 yrs. 
34 yrs. 
14 yrs. 
3 yrs. 
2 yrs. 
Sex 
M 
Clinical 
Days  type of 
after  poliomye- 
onset  lifts 
8  Paralytic 
29 
36 
6  Paralytic 
27 
10  Paralytic 
36 
18  Paralytic 
33 
49 
27  Paralytic 
41 
Virus 
isolated 
from 
stool 
Type I 
Type 1 
Type 1 
I Type 1 
Type 1 
Poliomyelitis  complement 
fixation  titers 
Unheated 
antigen 
Type Type  type 
1  2  3 
<8  <8  <8 
32  <8  <8 
16  <4  <4 
8  <4  <4 
16  <4  <4 
8  <4  <4 
32  <4  <4 
16  <4  <4 
64  <4  <4 
64  <4  <4 
32  <4  <4 
64  <4  <4 
Heated antigen 
rype Type Type Type Typel 
1  2  3  1  2 
<8  16  64  8  <4 
32  16  64  128  <4 
16  8  32  128  <4 
16  32  16  32  8 
16  16  8  128  8 
32  32  64  256  <4 
32  16  32  512  <4 
16  4  <4  64  <4 
16  <4  <4  512  <4 
16  <4  <4  1024  <4 
16  4  32  128  <4 
32  4  16  256  <4 
Poliomy.elitis 
neutralizing 
antibody 
titer* 
ryp~ 
3 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
<4 
* Determined by the method of Lipton and Steigmsn (4), using a HeLa cell culture system. 
and 9, for example, showed with  the heated  antigen  a rise in complement-fixing antibody 
to a virus  type to which they had no demonstrable  neutralizing  antibody.  (The convales- 
cent-phase serum of patient 4 was toxic to HeLa cells in dilutions up to 1:32, and it is as- 
sumed that no rise in neutralizing  antibody to Type 2 and Type 3 viruses occurred. Even 
if this individual is removed from subsequent consideration in the computation  of the total 
degree of heterotypic  fixation encountered,  the percentage  of cross-reactions is not greatly 
altered.)  In other individuals,  antibody reacting  with  heated  antigen  was  present  early 
after the onset of the illness, the titer did not change, and the antibody was present  at a 
fairly  high level for 6 or 7 weeks at least. 
The  findings  of the  complement  fixation tests  on the  18  individuals  with 
Type 1 infections may be summarized  as follows: With  the unheated  antigen, 
two individuals had stationary complement-fixing antibody titers to the Type 
1  virus,  and  the  sera  did  not  give  cross-reactions  with  Type  2  and  Type 
3 antigens. One individual showed a rise in antibody titer to the Type 1 virus 
and possessed a stationary antibody titer to the Type 3 virus, against which he 
also  possessed  neutralizing  antibodies.  Fifteen  individuals  showed  rises  in 
titer to the Type 1 virus but no reactions to the Type 2 or Type 3 virus anti- 
gens. With the heated antigens, on the other hand, 10 individuals with no Type 
2  or Type 3 neutralizing  antibody gave fixation against  these types, 3  of the 
10 actually showing rises in titer to Type 2 and Type 3 viruses. Four additional 
individuals  with  no neutralizing  antibody  to  the Type 3  virus gave fixation 
with the Type 3 antigen, 1 of these 4 showing a rise in titer to this type. The 10 114  POLIOMYELITIS  C-F  ANTIGENS 
cross-reactions with  the Type 2  heated antigen represent an incidence of 56 
per cent heterotypic reactions with the Type 2 virus, and the 14 individuals 
TABLE  VIII 
Lack of Reactivity of Heated and Unheated Poliomyelitis Virus Complement-Fixlng Antigens 
with Sera of Patients with Mumps Meningoencephalomyditis 
Complement-fixing titers with 
nays  Mumps 
Patient  after  C-F  Unheated antigens  Heated antigens 
onset  titer* 
Neutralizing  antibody 
titers~ 
Type  T~e]Type  Type  T~e  Type  Type  Type  T~e 
I  2  3  1  2  3  1  2  3 
21.  Bi.Ha.  6  <8  <4  <4  <4  <4  <4  <4  <4  <4  <4 
128  <4  <4  <4  <4  <4  <4  <4  <4  <4 
22.  G1.Mo.  3  16  <4  <4  <4  <4  <4  <4  <4  <4  <4 
23.  Vi.Ma.  9  16  <4  <4  <4  <4  <4  <4  <4  <4  128 
30  64  <8  <8  <8  <8  <8  <8  <8  <8  128 
24.  Be.Ca.  6  16  <4  <4  <4  <4  <4  <4  128  32  128 
30  64  <4  <4  <4  <4  <4  <4  64  32  64 
25.  Mi.Co.  21  64  4  <4  <4  <4  <4  <4  512  <4  <4 
26.  Da.Be.  10  16  32  <4  <4  8  <4  <4  128  128  8 
28  128  32  <4  <4  4  <4  <4  128  32  <4 
27.  Ja.Mc.  41  256  <8  8  <8  <8  16  <8  <16  512  <4 
28.  Do.AI.  3  <8  <4  64  <4  <4  64  <4  128  >2048  128 
23  16  <4  64  <4  <4  64  <4  128  >2048  128 
29.  Sa.Su.  16  64  <4  <4  <4  4  4  <4  128  256  32 
29  64  <4  <4  <4  4  8  <4  128  256  64 
30. Je.Ja.  15  32  <4  <4  <4  8  4  8  <4  32  8 
76  256  <8  <8  ,(8  <8  <8  <8  <4  4  <4 
* Antibody titer to the 
Titers determined by 
system. 
S (soluble) antigen of the mumps virus. 
the method of Salk eta/. (3) using monkey kidney tissue culture 
giving cross-reactions with the Type 3 heated antigen represent an incidence of 
78 per cent heterotypic fixation with this type. 
These findings indicate that the heterotypically reacting substances appear 
very early during the course of the infection and are generaly at their maximal 
level at the time of onset of the disease, although in some instances they appear 
with the onset of the illness, and increase in titer, as does the homotypic anti- N.  ~.  SCItM-IDT  AND  E.  H.  LENNETTE  115 
body. Also, they do not disappear promptly but persist for at least some weeks 
and probably longer. The remarkably high incidence of heterotypic reactions 
in  these  patients  together with  the  50  individuals described above suggests 
that the Type  1 virus is immunologically related to Types 2  and 3  and  that 
heat treatment of the homotypically specific native antigen uncovers a reactive 
group shared by all three virus types. The poliomyelitis infections we have seen 
have been due preponderantly to Type 1 virus; we have encountered only a  few 
Type 3 virus infections and fewer Type 2 infections, and studies on individuals 
infected with  these two viruses should help to elucidate further  the antigenic 
relationships suspected by others, and supported by these findings, to exist be- 
between the three immunologic types of poliomyelitis virus. 
Specificity for Poliomyelitis  Virus of the Reactions with Heated Antigens.-- 
The sera which reacted heterotypically with the heated poliomyelitis antigens 
gave no fixation with the heated control preparations. This suggested that the 
heterotypic reactions were  specific in  the  sense  that  fixation of  complement 
occurred only in the presence of some reactive moiety possessed by the polio- 
myelitis group of viruses. Evidence for such group specificity was afforded by 
the results of complement fixation tests with sera from patients in whom the 
clinical diagnosis was non-paralytic poliomyelitis, but who were subsequently 
shown to have mumps virus infections--no virus was recovered from the stools, 
and there was a rise in the antibody titer to the S (soluble) antigen of the mumps 
virus. 
Seventeen  sera from  10 such patients with mumps  meningoencephalomyelitis  were tested 
with  heated  and  unheated  poliomyelitis complement-fixing  antigens,  and  the  results are 
given in Table VIII. The sera of 4 patients (Nos. 21  through 24) gave no reactions  to any 
virus type with either heated or unheated antigens.  2 of these individuals possessed no de- 
monstrable neutralizing antibody to any of the three virus types, 1 had neutralizing anti- 
body to Type 3 virus only, and t  had neutralizing antibody to all three types. The serum 
of patient 25 gave fixation (minimal)  only with the unheated Type 1 antigen, and the  only 
demonstrable neutralizing antibody in this serum  was  to the Type 1 virus. 
Patient 26 gave fixation  with both unheated and heated Type 1 antigen, but not with 
antigens to the other types; patients 27 and 28 similarly gave fixation with both  unheated 
and heated Type 2 antigens,  but not with those of other virus types. In each instance neu- 
tralizing antibody corresponding  to the immunologic  type of the antigen which gave fixa- 
tion was present. 5 
5 The exact diagnosis in patient 28, however,  is uncertain.  The high complement-fixing 
and very high neutralizing antibody titers to the Type 2 virus point to this agent as the 
cause of the current illness. If this interpretation be made, then the rise, at a low level, of 
S antibody to the mumps virus must be regarded as evidence of a dual infection or as a non- 
specific reaction; in the latter case, the diagnostic significance of mumps S antibody is called 
into question.  On the other hand, the stationary poliomyelitis antibody titers may reflect 
a recent infection with Type 2 virus and the rising mumps antibody, current infection with 
this agent. This latter interpretation was made here and was based in part on the presence 
of a high Type 2 complement-fixing antibody titer at 3 days after the onset of illness; po- 
liomyelitis complement-fixing  antibody is generally slow in developing,  and  titers of this 
magnitude are not commonly encountered  so soon after onset. 116  POLIOMYELITIS C-]~  ANTIGENS 
Unheated antigens gave no fixation with the sera of patient 29, but borderline reactions 
occurred with heated Type 1 and Type 2 antigens. Since neutralizing antibody to all three 
virus types was present in the sera, and since cross-fixation can, as shown elsewhere above, 
occur between types in these circumstances, the  results are not unexpected. The findings 
with the sera of patient 30, however, are not readily explicable and should, in the interests 
TABLE  1X 
Attempts to Separate, by High Speed Centrifugation, Fraction Responsible  for Cross-Reactivlty 
of Heated Poliomyelitis Complement-Fixing Antigens 
Antigen 
Vimstype 
Type 1 (Mahoney 
Type 2 (Statler) 
Type 3 (McMul- 
len) 
Treatment 
None* 
Heated:~ 
None 
Heated 
None 
Heated 
Fractions tested  for antigenicity before and after 
centrifugation at 104,000 G for 3 hrs. 
I. Tissue culture fluid 
2.  Supernatant fluid 
3.  Sediment (resuspended pellet) 
1.  Tissue culture fluid 
2.  Supernatant fluid 
3.  Sediment (resuspended pellet) 
1. Tissue culture fluid 
2.  Superuatant fluid 
3.  Sediment (resuspended pellet) 
1.  Tissue culture fluid 
2.  Supernatant fluid 
3.  Sediment (resuspended pellet) 
1. Tissue culture fluid 
2.  Supernatant fluid 
3.  Sediment (resuspended pelet) 
1. Tissue culture fluid 
2.  Supernatant fluid 
3.  Sediment (resuspended pellet) 
Antigenic titer of 
fraction with  ho- 
mologous monkey 
immune serum 
1:8 
0 
1:4 
1:6 
0 
1:3 
1:8 
0 
1:6 
1:3 
0 
1:2 
1:4 
0 
1:3 
1:3 
1:4 
0 
1:3 
* Infectious, untreated material; i.e., native antigen. 
~/Infectious culture fluid heated at 56°C. for 30 minutes. 
of objectivity and in the light of the meager current  knowledge, be regarded as constitu- 
ting non-specific reactions. 
In so far as this small group of individuals is concerned, the observations on 
the whole indicate that  the reactivity of heated poliomyelitis antigens is es- 
sentially specific for the poliomyelitis  group of viruses. When complement-fixing 
antibodies were demonstrable with the use of native unheated antigen, neu- 
tralizing  antibody  of  the  corresponding  immunologic type  was  also  found 
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In two instances,  the heated antigen gave minimal degrees of fixation, while 
the unheated antigen did not give any fixation; one of these reactions seems 
attributable  to the neutralizing antibodies present in the serum, the other is 
regarded as non-specific. 
Factor Responsible for tteterotypic  Fixation  of Heated Antigens.-- 
Black and Melnick (12) observed that formalinization of their live vires antigens 
resulted in a variableloss of homotypie titer and an increase in cross-reactions  between 
the poliomyelitis virus types. Also, while most of the complement-fixing  antigen in 
the untreated preparations could be sedimented by high speed centrifugation, forma- 
lin treatment released  a "soluble antigen" which remained in the supernatant fluid. 
Heated  and  unheated  antigens (infected HeLa cell culture fluids) were centrifuged at 
104,000 gravity for 3 hours. The supernatant fluids were completely removed and the sedi- 
ments were resuspended to the  original volume with Kolmer saline solution. The original 
starting  materials,  the  supematant  fluids, and  the  resuspended sediments were titrated 
for  complement-fixing anfigenicity with  homologous monkey immune sera. The  comple- 
ment-fixing titers  of  the  various  preparations  are  given in  Table  IX. 
Under the conditions of these experiments, no evidence of a soluble antigen 
such as that encountered by Black and Melnick (12)  was found. The comple- 
ment-fixing activity of the centrifuged preparations was confined to the sedi- 
ments; the supernatant fluids exhibited no demonstrable activity. It has yet 
to  be  determined,  however,  whether  the  heat  treatment  employed was  not 
sufficiently stringent to release the factors uncovered by formalinization, despite 
the fact that the treatment was adequate to induce a heterotypic reactivity of 
the antigens. 
DISCUSSION 
If the complement fixation test for poliomyelitis is to be utilized by clinical 
and public health laboratories unfamiliar with the handling of viruses, elimina- 
tion of the potential infection hazard is desirable. It was considered that this 
might be achieved by heating the virus-containing tissue culture fluids, which 
constitute the antigen, for 30 minutes at 56°C. It was found, however, that such 
treatment, while it does not completely destroy the complement-fixing capacity 
of  the  antigen,  does  adversely  affect  its  potency  and  sensitivity.  The  loss 
in antigenic potency encountered was of the magnitude of 25  to 30 per cent 
and  losses as high  as 50  per cent  were encountered.  Such  losses of activity 
militate against the use of heat as a  means of abolishing infectivity, and are 
not in accord with reports that heat does not significantly reduce antigenicity. 
Aside from the reduction in  complement-fixing capacity and in sensitivity, 
heat treatment did not seem otherwise to affect the antigens in so far as tests 
with monkey immune sera were concerned. The heated antigens gave virtually 
as sharply homotypic  fixation  as  did  the  unheated  preparations with  both 
homotypic and heterotypic monkey immune sera.  Others  (5,  6,  12)  have re- 
ported  similar experiences.  It would  thus  appear that  this absence of cross- 
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experimental work or for purposes of titrating  the preparations for antigenic 
unitage,  is the basis for reported impressions that homotypic specificity is un- 
affected by heat treatment. 
However,  with  human  sera  there  is  a  marked  difference  in  homotypic 
specificity  between  heated  and  unheated  antigens.  Our  unheated  antigens 
tended rather uniformly to give homotypic fixation, whereas the heated anti- 
gens gave a  very high  proportion  of cross-reactions.  In a  series of 50  single 
serum  specimens,  the  incidence  of heterotypic reactions  was  10  per cent  to 
Type 1 virus, 56 per cent to Type 2 virus, and 34 per cent to Type 3 virus. 
When paired or multiple serum specimens from patients with a clinical diagnosis 
of  poliomyelitis  were  tested,  no  cross-reactions  were  encountered  with  the 
Type 1 virus, but  the incidence of heterotypic fixations to the Type 2 virus 
was 56 per cent and to the Type 3 virus, 78 per cent. The loss of homotypic 
specificity, or conversely, the broad reactivity engendered by heat treatment 
of  the  poliomyelitis  complement-fixing  antigens,  explains  the  heterotypic 
fixation reported by a number of investigators, who use heat-treated antigens. 
Svedmyr (10), for example, reported that the complemenl fixation test was posi- 
tive in 90 per cent of the cases of poliomyelitis tested, but the incidence of homotypic 
reactions was only 10 per cent. Black (9) has observed that 90 per cent of poliomyelitis 
patients possess complement-fixing  antibodies against two or three types of the virus, 
and that most individuals  who give heterotypie fixation  have neutralizing antibody 
to more than one type, but not necessarily  to the same type as their complement- 
fixing antibodies. His experience  (9) agrees with that of others, and is supported by 
our findings with heated antigens,  that complement-fixing  antibody may be present 
very early in the disease  and show no subsequent rise in titer, and thai  changes in 
titer between multiple sera may occur in almost any combination. Thus, "the homo- 
typic titer may rise as the heterotypic falls; the titer against more than one type may 
rise simultaneously; or one or another type may be approximately the same in acute 
and  convalescent specimens" (9).  Black also  summarizes the  experience  of  others 
when he points out that while the type of complement-fixing  antibody showing  the 
largest rise in titer frequently corresponds  with the type of the virus isolated from 
the stool, there are exceptions;  hence, such serologic results cannot be depended upon 
as identifying the type of the infecting  virus. 
On the basis of the experience recorded in this paper, we consider it necessary, 
pending  development  of  a  method  that  will  inactivate  the  virus  without 
broadening  the  reactivity of  the  antigen,  to  use  fully infectious  antigens if 
heterotypic reactions  are  to be avoided and  if identification  of the  infecting 
virus type is desired. Heated antigens may, perhaps, have some virtue for early 
diagnosis (2, 11) since antibody to any virus type or types may be detectable at, 
or shortly after, onset of the disease. However, the question arises whether, in 
any particular  patient,  the  mere presence of heterotypic antibody,  in  either 
low titer or at a  high stationary level, is diagnostically significant per se, i.e., 
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poliomyelitis complement-fixing antibodies may persist for some months after 
infection (unpublished data), and thus may be present, and their significance 
misinterpreted,  in  patients  suffering from diseases  other  than poliomyelitis 
(cf.  Table VIII and references i and 16). In epidemiologic studies, on the other 
hand, the relatively short persistence of complement-fixing antibody suggests 
that its presence may be regarded as evidence of recent, not necessarily current, 
infection. Since, in such studies, knowledge of the specific  infecting type is a 
desideratum, homotypically specific antigens are preferable to heterotypically 
reactive preparations. 
Sabin (14) has observed that patients with a Type 1 poliomyelitis virus infection 
may develop a minimal and transitory heterotypic neutralizing  antibody response 
to the Type 2 virus;  this association has been interpreted to indicate  an antigenic 
relationship  between at least some strains  of the Type 1 and Type 2 poliomyelitis 
viruses. It has also been suggested (6, 15) that heterotypic fixation of complement is 
based  on the existence of an antigenic relationship  between all three  poliomyelitis 
virus types. The work reported here adds additional evidence for the existence of an 
antigenic overlapping between types. Also, this sharing of a common antigen(s) may 
perhaps explain Melnick's (17) finding of complement-fixing antibodies in the sera of 
normal  children  without demonstrable  neutralizing  antibodies,  namely,  that  the 
complement-fixing antibodies represent a heterotypic response induced by a Type 4 
poliomyeiilis virus  (17). It would be of interest to ascertain  whether any agents of 
the "orphan" group can give rise to such heterotypic responses. 
Since the unheated antigens reacted homotypically but became highly cross- 
reactive after heating, the treatment must have brought about a  broadening 
of the normally type-specific reactive component, or exposed a group-reactive 
moiety otherwise not in evidence. Other observations also indicate that physical 
methods can  bring  about  a  change  from  type-specific reactivity  to  group- 
specific  reactivity in  the  poliomyelitis viruses.  LeBouvier (2),  for example, 
observed that ultraviolet irradiation, like heat, bestows a  cross-reactivity on 
previously type-specific complement-fixing antigens.  We  (unpublished data) 
and others  (7)  have observed that whereas monkeys inoculated with active 
poliomyelitis virus respond  with  the  production of homotypic complement- 
fixing  antibodies,  animals  inoculated  with  monovalent  formalinized  virus 
preparations tend to produce heterotypic complement-fixing antibody. 
What the nature of the group-reactive substance  may be  is still unclear. 
Black and Melnick (12) found that while their active virus preparations were 
almost completely  type-specific, formalinization  made the antigens cross-reactive. 
Moreover, most of the complement-fixing activity in the live virus preparations 
could be sedimented by high-speed centrifugation, whereas in the formalinized 
preparations, considerable complement-fixing activity remained in the super- 
natant fluid, suggesting the presence of a  "soluble" antigen.  Similar attempts 
by us at centrifugal separation of a reactive fraction from heated preparations 
yielded no indication that a  soluble antigen was involved. It is possible that 120  POLIOMYELITIS  C-F  ANTIGENS 
formalinization brings about changes not elicited by heat treatment as employed 
by us, although such treatment was adequate to induce a high degree of cross- 
reactivity. 
Finally, the  cross-reactivity conferred on poliomyelitis complement-fixing 
antigens by heating appears to be essentially specific for the poliomyelitis group 
of viruses. That it is not a non-specific reactivity is suggested from preliminary 
experiments in which the heterotypically reactive heated antigens did not fix 
complement in the presence  of sera  from patients with mumps meningoen- 
cephalomyelitis unless these sera also contained neutralizing antibody to one 
or another of the three immunologic types of poliomyelitis virus. 
SUM'~ARY 
Fluid obtained from HeLa cell  cultures infected with poliomyelitis  viruses 
served as a  complement-fixing antigen. When used  in  the native state,  i.e. 
untreated in any way, the fluids acted as homotypically  specific antigens. When 
heated, however, the antigenicity was broadened and a high degree of hetero- 
typiq reactivity was encountered. 
Data are presented indicating that the observed group reactivity was ap- 
parently based on common antigens shared by the three immunologic types of 
poliomyelitis virus. This reactivity appeared to be specific for the poliomyelitis 
viruses. No evidence was obtained in preliminary experiments that heating of 
the antigens releases a "soluble" antigen responsible for the group reactivity. 
We are indebted to Miss Anna Weiner for the isolation and typing of viruses from the 
patients and to Mr. Tak Shinomoto  for assistance in performing the colorimetric neutrali- 
zation tests. 
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